Immunome Raises $12.2 Million in Additional Series A Financing

Previous PostRelmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms